170 related articles for article (PubMed ID: 2535737)
21. Crystallization and preliminary x-ray diffraction studies of the Fab fragment of a neutralizing monoclonal antibody directed against human rhinovirus serotype 2.
Tormo J; Fita I; Kanzler O; Blaas D
J Biol Chem; 1990 Oct; 265(28):16799-800. PubMed ID: 2170356
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of neutralization of influenza virus infectivity by antibodies.
Knossow M; Gaudier M; Douglas A; Barrère B; Bizebard T; Barbey C; Gigant B; Skehel JJ
Virology; 2002 Oct; 302(2):294-8. PubMed ID: 12441073
[TBL] [Abstract][Full Text] [Related]
23. Relationship between poliovirus neutralization and aggregation.
Thomas AA; Vrijsen R; Boeyé A
J Virol; 1986 Aug; 59(2):479-85. PubMed ID: 3016307
[TBL] [Abstract][Full Text] [Related]
24. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
[TBL] [Abstract][Full Text] [Related]
25. Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2.
Barnett PV; Rowlands DJ; Parry NR
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1295-302. PubMed ID: 8393073
[TBL] [Abstract][Full Text] [Related]
26. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.
Edwards MJ; Dimmock NJ
J Gen Virol; 2001 Jun; 82(Pt 6):1387-1395. PubMed ID: 11369883
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
Ruggeri FM; Greenberg HB
J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
[TBL] [Abstract][Full Text] [Related]
28. Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited.
Armstrong SJ; Dimmock NJ
J Virol; 1992 Jun; 66(6):3823-32. PubMed ID: 1583731
[TBL] [Abstract][Full Text] [Related]
29. Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
Men R; Yamashiro T; Goncalvez AP; Wernly C; Schofield DJ; Emerson SU; Purcell RH; Lai CJ
J Virol; 2004 May; 78(9):4665-74. PubMed ID: 15078949
[TBL] [Abstract][Full Text] [Related]
30. Purification and crystallization of intact human rhinovirus complexed with a neutralizing Fab.
Smith TJ; Chase ES
Virology; 1992 Dec; 191(2):600-6. PubMed ID: 1333115
[TBL] [Abstract][Full Text] [Related]
31. Complexes between monoclonal antibodies and receptor fragments with a common cold virus: determination of stoichiometry by capillary electrophoresis.
Okun VM; Moser R; Blaas D; Kenndler E
Anal Chem; 2001 Aug; 73(16):3900-6. PubMed ID: 11534714
[TBL] [Abstract][Full Text] [Related]
32. Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility.
Smith TJ; Olson NH; Cheng RH; Chase ES; Baker TS
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7015-8. PubMed ID: 8394005
[TBL] [Abstract][Full Text] [Related]
33. Isolation of human monoclonal antibodies that neutralize human rotavirus.
Higo-Moriguchi K; Akahori Y; Iba Y; Kurosawa Y; Taniguchi K
J Virol; 2004 Apr; 78(7):3325-32. PubMed ID: 15016854
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.
Highlander SL; Cai WH; Person S; Levine M; Glorioso JC
J Virol; 1988 Jun; 62(6):1881-8. PubMed ID: 2452895
[TBL] [Abstract][Full Text] [Related]
35. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors.
Pevear DC; Fancher MJ; Felock PJ; Rossmann MG; Miller MS; Diana G; Treasurywala AM; McKinlay MA; Dutko FJ
J Virol; 1989 May; 63(5):2002-7. PubMed ID: 2539499
[TBL] [Abstract][Full Text] [Related]
36. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies.
Fuller AO; Spear PG
J Virol; 1985 Aug; 55(2):475-82. PubMed ID: 2991570
[TBL] [Abstract][Full Text] [Related]
37. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
[TBL] [Abstract][Full Text] [Related]
38. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
Icenogle J; Shiwen H; Duke G; Gilbert S; Rueckert R; Anderegg J
Virology; 1983 Jun; 127(2):412-25. PubMed ID: 6306918
[TBL] [Abstract][Full Text] [Related]
39. Neutralization of animal virus infectivity by antibody.
Reading SA; Dimmock NJ
Arch Virol; 2007; 152(6):1047-59. PubMed ID: 17516034
[TBL] [Abstract][Full Text] [Related]
40. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
Edwards MJ; Dimmock NJ
J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
